novità residuo Popolare annals of clinical and translational neurology impact factor punto finale Fare un bagno Fuorilegge
ANA Journals (@ANA_journals) / Twitter
Cureus | Rituximab in the Management of Refractory Myasthenia Gravis and Variability of Its Efficacy in Anti-MuSK Positive and Anti-AChR Positive Myasthenia Gravis
2020 Emerging Science Abstracts | Neurology
PDF) Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients